Company number 09818825
Status Active
Incorporation Date 12 October 2015
Company Type Private Limited Company
Address 84 AVONDALE AVENUE, LONDON, ENGLAND, N12 8EN
Home Country United Kingdom
Nature of Business 26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
Phone, email, etc
Since the company registration eleven events have happened. The last three records are Total exemption small company accounts made up to 31 October 2016; Resolutions
RES11 ‐
Resolution of removal of pre-emption rights
RES10 ‐
Resolution of allotment of securities
; Statement of capital following an allotment of shares on 20 October 2016
GBP 121.49
. The most likely internet sites of BIOSELF TECHNOLOGY LTD are www.bioselftechnology.co.uk, and www.bioself-technology.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and four months. Bioself Technology Ltd is a Private Limited Company.
The company registration number is 09818825. Bioself Technology Ltd has been working since 12 October 2015.
The present status of the company is Active. The registered address of Bioself Technology Ltd is 84 Avondale Avenue London England N12 8en. The company`s financial liabilities are £101.56k. It is £101.56k against last year. The cash in hand is £80.86k. It is £80.86k against last year. And the total assets are £111.57k, which is £111.57k against last year. ALLEN, Grant, Dr is a Director of the company. CHMELIK, Stefan is a Director of the company. GILL, Nicholas is a Director of the company. SKINNER, Jacob Charles, Dr is a Director of the company. The company operates in "Manufacture of irradiation, electromedical and electrotherapeutic equipment".
bioself technology Key Finiance
LIABILITIES
£101.56k
CASH
£80.86k
TOTAL ASSETS
£111.57k
All Financial Figures
Current Directors
Persons With Significant Control
Mr Stefan Chmelik
Notified on: 11 October 2016
62 years old
Nature of control: Ownership of shares – 75% or more
BIOSELF TECHNOLOGY LTD Events
16 Mar 2017
Total exemption small company accounts made up to 31 October 2016
09 Feb 2017
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES10 ‐
Resolution of allotment of securities
08 Feb 2017
Statement of capital following an allotment of shares on 20 October 2016
03 Nov 2016
Confirmation statement made on 11 October 2016 with updates
22 Aug 2016
Appointment of Dr Jacob Charles Skinner as a director on 21 July 2016
...
... and 1 more events
22 Aug 2016
Appointment of Nicholas Gill as a director on 21 July 2016
22 Aug 2016
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES12 ‐
Resolution of varying share rights or name
-
RES13 ‐
Sub div 20/07/2016
-
RES01 ‐
Resolution of adoption of Articles of Association
19 Aug 2016
Sub-division of shares on 20 July 2016
17 Aug 2016
Change of share class name or designation
12 Oct 2015
Incorporation
Statement of capital on 2015-10-12